Sang-Joon Lee
Chief Executive Officer en HYUNDAI PHARMACEUTICAL CO., LTD. .
Fortuna: 4 M $ al 31/03/2024
Perfil
Sang-Joon Lee is currently the President, CEO, Director, and Head of R&D at Hyundai Pharmaceutical Co., Ltd.
He is also the Chief Executive Officer at Bioinnotis.
Mr. Lee holds an MBA from the University of San Diego.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 28/02/2023 | 1 351 612 ( 4.22% ) | 4 M $ | 31/03/2024 |
Cargos activos de Sang-Joon Lee
| Empresas | Cargo | Inicio |
|---|---|---|
| HYUNDAI PHARMACEUTICAL CO., LTD. | Chief Executive Officer | 28/02/2003 |
Bioinnotis
 Bioinnotis Miscellaneous Commercial ServicesCommercial Services Bioinnotis is a research institute that focuses on developing innovative pharmaceutical drugs and technologies. The private company is based in Seoul, South Korea. The CEO of the South Korean company is Sang-Joon Lee. | Chief Executive Officer | - |
Formación de Sang-Joon Lee.
| University of San Diego | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| HYUNDAI PHARMACEUTICAL CO., LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Bioinnotis
Bioinnotis Miscellaneous Commercial ServicesCommercial Services Bioinnotis is a research institute that focuses on developing innovative pharmaceutical drugs and technologies. The private company is based in Seoul, South Korea. The CEO of the South Korean company is Sang-Joon Lee. | Commercial Services |
- Bolsa de valores
- Insiders
- Sang-Joon Lee
